KMG Fiduciary Partners LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 14,249 shares of the medical equipment provider’s stock after acquiring an additional 21 shares during the quarter. KMG Fiduciary Partners LLC’s holdings in Intuitive Surgical were worth $7,437,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at $36,000. Mark Sheptoff Financial Planning LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $37,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Stock Up 0.7 %
ISRG opened at $584.08 on Friday. The business has a fifty day moving average of $538.34 and a 200 day moving average of $497.08. The stock has a market cap of $208.04 billion, a P/E ratio of 93.90, a PEG ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $355.17 and a 52-week high of $585.50.
Analyst Ratings Changes
A number of equities research analysts have commented on the company. Stifel Nicolaus raised their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. BTIG Research upped their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Raymond James lifted their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Finally, Citigroup upped their price objective on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $554.17.
Check Out Our Latest Analysis on Intuitive Surgical
Insider Buying and Selling
In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the transaction, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This trade represents a 88.63 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock worth $25,012,927 in the last 90 days. 0.80% of the stock is owned by corporate insiders.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- How to Read Stock Charts for Beginners
- Is Johnson & Johnson Stock Set to Reward Long-Term Holders?
- Best Stocks Under $5.00
- Buffett’s Sale of BAC Stock: A Smart Move or Missed Opportunity?
- 3 Warren Buffett Stocks to Buy Now
- Energy Sector Shines in 2025: 2 Stocks Leading the Charge
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.